
BT Slingsby describes his education and career abroad, which ultimately led him to found and manage the largest life sciences VC firm in Japan, Catalys Pacific. He describes the dual role of taking assets from Japan and building companies around them internationally., and also in-licensing assets approved elsewhere and doing the clinical work in Japan to get them approved there. Plus, the story of the GHIT Fund, which is meant to bring Japanese innovation to neglected diseases around the world.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Episode 47: Ally Bridge's Andrew Lam

Episode 45: Catalio Capital Management's George Petrocheilos

Episode 44: BainCapital's Adam Koppel

Episode 43: Lightstone Venture's Mike Carusi
Free AI-powered recaps of BioVenture VoiCes with Chris Garabedian and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.